TrialWorld journal of gastroenterology2014

Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.

Danuta Chmielewska-Wilkoń et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.